Cargando…

Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy

BACKGROUND: A phase III clinical trial has already shown the survival benefits of postoperative chemotherapy in gastric cancer. However, there are limited published data concerning the elderly. This study aims to investigate the use of adjuvant chemotherapy for gastric cancer after D2 gastrectomy am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Ying, Qiu, Miao-zhen, Wang, De-shen, Zhang, Dong-sheng, Ren, Chao, Bai, Long, Luo, Hui-yan, Wang, Zhi-qiang, Wang, Feng-hua, Li, Yu-hong, Xu, Rui-hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554736/ https://www.ncbi.nlm.nih.gov/pubmed/23359796 http://dx.doi.org/10.1371/journal.pone.0053149

Ejemplares similares

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
por: Yang, Lu-Ping, et al.
Publicado: (2019)

S-1-Based Chemotherapy versus Capecitabine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Carcinoma: A Meta-Analysis
por: He, Ming-ming, et al.
Publicado: (2013)

Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer
por: Bao, Huizheng, et al.
Publicado: (2017)

Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis
por: Bai, Long, et al.
Publicado: (2016)

Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer
por: Ren, Chao, et al.
Publicado: (2012)

A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy
por: Wang, Nan, et al.
Publicado: (2021)

Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer
por: Chen, Dong-liang, et al.
Publicado: (2013)

Laparoscopic gastrectomy for elderly gastric-cancer patients: comparisons with laparoscopic gastrectomy in non-elderly patients and open gastrectomy in the elderly
por: Li, Zheng-Yan, et al.
Publicado: (2020)

Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study
por: Ren, Deng-Feng, et al.
Publicado: (2018)

The Tumor-Log Odds of Positive Lymph Nodes-Metastasis Staging System, a Promising New Staging System for Gastric Cancer after D2 Resection in China
por: Qiu, Miao-zhen, et al.
Publicado: (2012)

Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer
por: Serrano, Mariana, et al.
Publicado: (2022)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
por: Yu, Shan, et al.
Publicado: (2020)

Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor
por: Peng, Wei, et al.
Publicado: (2022)

DNA polymeraseη protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy
por: Teng, Kai-yuan, et al.
Publicado: (2010)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
por: Guo, Jianping, et al.
Publicado: (2023)

Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
por: Huang, Jiao-Bao, et al.
Publicado: (2021)

Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy
por: Wu, Bin, et al.
Publicado: (2014)

Why a D2 gastrectomy plus adjuvant chemotherapy is insufficient in locally advanced gastric cancer
por: Sebastián Solé, Z, et al.
Publicado: (2016)

Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2021)

Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China
por: Qiu, Miao-zhen, et al.
Publicado: (2013)

The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?
por: Wang, Yun, et al.
Publicado: (2017)

Outcomes of Laparoscopic Total Gastrectomy for Elderly Gastric Cancer Patients
por: Sheng, Shihou, et al.
Publicado: (2018)

The survival benefit of palliative gastrectomy and/or metastasectomy in gastric cancer patients with synchronous metastasis: a population-based study using propensity score matching and coarsened exact matching
por: Yang, Lu-Ping, et al.
Publicado: (2019)

Laparoscopic gastrectomy for elderly patients with gastric cancer: A systematic review with meta-analysis
por: Pan, Yu, et al.
Publicado: (2018)

Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer
por: Yuan, Shu-Qiang, et al.
Publicado: (2017)

Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy
por: Cho, Jang Ho, et al.
Publicado: (2017)

Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II‐III gastric cancer
por: Yuan, Shu‐Qiang, et al.
Publicado: (2023)

Comparison of short-term efficacy between totally laparoscopic gastrectomy and laparoscopic assisted gastrectomy for elderly patients with gastric cancer
por: Zhao, Rui-Yang, et al.
Publicado: (2022)

Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses
por: Zhou, Meng-Long, et al.
Publicado: (2019)

Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis
por: Wu, Pei, et al.
Publicado: (2018)

Adjuvant chemotherapy may be unnecessary for ypT0-2N0 gastric cancer patients after neoadjuvant chemotherapy and curative gastrectomy
por: Shao, Xinxin, et al.
Publicado: (2023)

Lymph node staging systems in patients with gastric cancer treated with D2 resection plus adjuvant chemotherapy
por: Zhou, Yi-Xin, et al.
Publicado: (2018)

Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases
por: Wang, Yun, et al.
Publicado: (2016)

Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy
por: Xiao, Hua, et al.
Publicado: (2020)

Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis
por: Zhao, Jun-hua, et al.
Publicado: (2016)

Phase II clinical trial of S‐1 plus nanoparticle albumin‐bound paclitaxel in untreated patients with metastatic gastric cancer
por: He, Ming‐ming, et al.
Publicado: (2018)

Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer
por: Zhu, Yue-Ting, et al.
Publicado: (2020)

A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy
por: Shi, Litong, et al.
Publicado: (2022)

Prognostic factors for gastrectomy in elderly patients with gastric cancer
por: Ueno, Daisuke, et al.
Publicado: (2017)

Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T(3-4a)N0M0 Gastric Cancer Patients after D2 Gastrectomy
por: Chen, Shi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_idp947tnu37roq4h1cbesr5u2f